Literature DB >> 2017193

Synthetic peptides as the basis for vaccine design.

R Arnon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2017193     DOI： 10.1016/0161-5890(91)90063-p

Source DB:  PubMed          Journal:  Mol Immunol        ISSN： 0161-5890            Impact factor:   4.407


× No keyword cloud information.
  8 in total

1.  Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.

Authors:  R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

2.  Peptides isolated from random peptide libraries on phage elicit a neutralizing anti-HIV-1 response: analysis of immunological mimicry.

Authors:  K Lundin; A Samuelsson; M Jansson; J Hinkula; B Wahren; H Wigzell; M A Persson
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

3.  Expression of a recombinant chimeric protein of hepatitis A virus VP1-Fc using a replicating vector based on Beet curly top virus in tobacco leaves and its immunogenicity in mice.

Authors:  Ho Yong Chung; Hyun Ho Lee; Kyung Il Kim; Ha Young Chung; Jeon Hwang-Bo; Jong Hwa Park; Garry Sunter; Jong Bum Kim; Dong Hwa Shon; Wonyong Kim; In Sik Chung
Journal:  Plant Cell Rep       Date:  2011-03-27       Impact factor: 4.570

Review 4.  Synthetic peptides in biochemical research.

Authors:  D C Hancock; N J O'Reilly; G I Evan
Journal:  Mol Biotechnol       Date:  1995-08       Impact factor: 2.695

5.  Identification of mimotope peptides which bind to the mycotoxin deoxynivalenol-specific monoclonal antibody.

Authors:  Q Yuan; J J Pestka; B M Hespenheide; L A Kuhn; J E Linz; L P Hart
Journal:  Appl Environ Microbiol       Date:  1999-08       Impact factor: 4.792

6.  A mimotope peptide-based vaccine against Schistosoma mansoni: synthesis and characterization.

Authors:  R Arnon; R Tarrab-Hazdai; M Steward
Journal:  Immunology       Date:  2000-12       Impact factor: 7.397

7.  Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization.

Authors:  Y Tanaka; R Tanaka; E Terada; Y Koyanagi; N Miyano-Kurosaki; N Yamamoto; E Baba; M Nakamura; H Shida
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.

Authors:  Xingmei Qi; Sidong Xiong
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.